Anaphylaxis during radiological procedures and in the peri-operative setting

Anaphylaxis and Hypersensitivity Reactions

Volumn , Issue , 2011, Pages 183-208

  Dewachter, Pascale ^b   Hepner, David L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Anaphylaxis; Anesthesia; Contrast media; Epinephrine; Histamine; Hypersensitivity; Immediate; Premedication; Skin tests; Tryptases

Indexed keywords

EID: 84864583274     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-951-2_11     Document Type: Chapter

References (147)

1. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813-824.
2. Harper NJ, Dixon T, Dugue P, et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009;64:199-211.
3. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
4. Liberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010;126:477-480.
5. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary Report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-397.
6. Shehadi WH. Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med 1975;124:145-152.
7. Shehadi WH, Toniolo G. Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology. Radiology 1980;137:299-302.
8. Ansell G, Tweedie MC, West CR, et al. The current status of reactions to intravenous contrast media. Invest Radiol 1980;15(Suppl):S32-S39.
9. Palmer FJ. The RACR survey of intravenous contrast media reactions. Final report. Australas Radil. 1988;32:426-428.
10. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A Report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-628.
11. Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high-vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol 1991;156:825-832.
12. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997;203:605-610.
13. Agence Nationale pour le Développement de l'Évaluation Médicale. Eléments d'Evaluation pour le Choix et l'Emploi des Différentes Classes de Produits de Contraste Iodés Hydrosolubles lors des Examens Tomodensitométriques et Urographiques. Paris: ANDEM; 1994.
14. Spring DB, Bettmann MA, Barkan HE. Deaths related to iodinated contrast media reported spontaneously to the U.S. Food and Drug Administration, 1978-1994: effect of the availability of low-osmolality contrast media. Radiology 1997;204:333-337.
15. Li A, Wong CS, Wong MK, et al. Acute adverse reactions to magnetic resonance contrast media-gadolinium chelates. Br J Radiol 2006;79:368-371.
16. Herborn CU, Honold E, Wolf M, et al. Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 2007;42:58-62.
17. Tardy B, Guy C, Barral G, et al. Anaphylactic shock induced by intravenous gadopentetate dimeglumine. Lancet 1992;339:494.
18. Meuli RA, Maeder P. Life-threatening anaphylactoid reaction after i.v. injection of gadoterate meglumine. AJR Am J Roentgenol 1996;166:729.
19. Beaudouin E, Kanny G, Blanloeil Y, et al. Anaphylactic shock induced by gadoterate meglumine (Dotarem). Eur Ann Allergy Clin Immunol 2003;35:382-385.
20. Kalogeromitros DC, Makris MP, Aggelides XS, et al. Anaphylaxis to gadobenate dimeglumine (Multihance): a case report. Int Arch Allergy Immunol 2007;144:150-154.
21. Hasdenteufel F, Luyasu S, Renaudin JM, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J Allergy Clin Immunol 2008;121:527-528.
22. Runge VM. Allergic reactions to gadolinium chelates. AJR Am J Roentgenol 2001;177:944-945.
23. Fisher MM, More DG. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 1981;9:226-234.
24. Fisher MM. The epidemiology of anaesthetic anaphylactoid reactions in Australasia. Klin Wochenschr 1982;60:1017-1020.
25. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993;12:97-104.
26. Galletly DC, Treuren BC. Anaphylactoid reactions during anaesthesia. Seven years' experience of intradermal testing. Anaesthesia 1985;40:329-333.
27. Watkins J. Adverse anaesthetic reactions. An update from a proposed national reporting and advisory service. Anaesthesia 1985;40:797-800.
28. Watkins J. Allergic and pseudoallergic mechanisms in anesthesia. Int Anesthesiol Clin 1985;23:17-40.
29. Watkins J. The allergic reaction to intravenous induction agents. Br J Hosp Med 1986;36:45-48.
30. Watkins J. Investigation of allergic and hypersensitivity reactions to anaesthetic agents. Br J Anaesth 1987;59:104-111.
31. Pepys J, Pepys EO, Baldo BA, et al. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthesia 1994;49:470-475.
32. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001;87:549-558.
33. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-545.
34. Mertes PM, Laxenaire MC. Épidémiologie des réactions anaphylactiques et anaphylactoïdes peranesthésiques en France. Septième enquête multicentrique (Janvier 2001-Décembre 2002). Ann Fr Anesth Reanim 2004;23:1133-1143.
35. Garvey LH, Roed-Petersen J, Menne T, et al. Danish Anaesthesia Allergy Centre: preliminary results. Acta Anaesthesiol Scand 2001;45:1204-1209.
36. Harboe T, Guttormsen AB, Irgens A, et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005;102:897-903.
37. Lobera T, Audicana MT, Pozo MD, et al. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain. J Investig Allergol Clin Immunol 2008;18:350-356.
38. Youngman PR, Taylor KM, Wilson JD. Anaphylactoid reactions to neuromuscular blocking agents: a commonly undiagnosed condition? Lancet 1983;2:597-599.
39. Hatton F, Tiret L, Maujol L, et al. Enquête épidé miologique sur les anesthésies. Ann Fr Anesth Reanim 1983;2:333-385.
40. Whittington T. Anaphylactic and anaphylactoid reactions. Baillières Clin Anaesthesiol 1998;12:301-323.
41. Laxenaire MC. Épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multi-centrique (Juillet 1994-Décembre 1996). Ann Fr Anesth Reanim 1999;18:796-809.
42. Currie M, Webb RK, Williamson JA, et al. The Australian Incident Monitoring Study. Clinical anaphylaxis: An analysis of 2000 incident reports. Anaesth Intensive Care 1993;21:621-625.
43. Mitsuhata H, Hasegawa J, Matsumoto S, et al. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan: A survey with a questionnaire of 529 hospitals approved by Japan Society of Anesthesiology. Masu. 1992;41:1825-1831.
44. Lienhart A, Auroy Y, Pequignot F, et al. Survey of anesthesia-related mortality in France. Anesthesiology 2006;105:1087-1097.
45. The Association of Anaesthetists of Great-Britain and Ireland and British Society for Allergy and Clinical Immunology. Suspected anaphylactic reactions associated with anaesthesia. Revised Edition 2003. http://www.aagbi.org/ publications/guidelines/docs/anaphylaxis03.pdf. Accessed December 14, 2009.
46. Dewachter P, Mouton-Faivre C. What investigation after an anaphylactic reaction during anaesthesia? Curr Opin Anaesthesiol. 2008;21:363-368.
47. Kroigaard M, Garvey LH, Gillberg L, et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007;51:655-670.
48. French Society of Anesthesiology and Intensive Care Medicine. Reducing the risk of anaphylaxis during anaesthesia. Abbreviated text. Ann Fr Anesth Reanim 2002;21(Suppl 1):7-23.
49. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003;97:1381-1395.
50. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;1:466-469.
51. Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology 2009;111:1141-1150.
52. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 2006;110:7-14.
53. Cabaton J, Rondelet B, Gergele L, et al. Un syndrome de Tako-Tsubo secondaire à un choc anaphylactique à la succinylcholine lors d'une anesthésie génerale. Ann Fr Anesth Reanim 2008;27:854-857.
54. Suk E, Kim D, Kweon T, et al. Stress-induced cardiomyopathy following cephalosporin-induced anaphylactic shock during general anesthesia. Can J Anaesth 2009;56:432-436.
55. Han Y, Yeon S. Midventricular hypokinesis as a cardiac manifestation of anaphylaxis: a case report. J Am Soc Echocardiogr 2006;19:1529 e9-e11.
56. Zubrinich C, Farouque H, Rochford S, et al. Tako-tsubo-like cardiomyopathy after EpiPen administration. Intern Med J 2008;38:862-865.
57. Litvinov I, Kotowycz M, Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the "broken heart syndrome." Clin Res Cardiol 2009;98:457-462.
58. Manivannan V, Li J, Prasad A, et al. Apical ballooning syndrome after administration of intravenous epinephrine during an anaphylactic reaction. Mayo Clin Proc 2009;84:845-846.
59. Abraham J, Mudd JO, Kapur N, et al. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009;53:1320-1325.
60. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J 2008;155:408-417.
61. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin N Am 2007;27:309-326.
62. Simons FER. Anaphylaxis, killer-allergy: long term management in the community. J Allergy Clin Immunol 2006;117:367-377.
63. Hepner DL, Castells MC. Latex allergy: an update. Anesth Analg 2003;96:1219-1229.
64. Campagna J, A, Carter C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 2003;98:1250-1260.
65. Delaunay F, Blasco V. Choc anaphylactique au latex en cours de césarienne: a propos de deux cas survenus en Guadeloupe. Ann Fr Anesth Reanim 2008;27:1023-1025.
66. Turillazzi E, Greco P, Neri M, et al. Anaphylactic latex reaction during anaesthesia: the silent culprit in a fatal case. Forensic Sci Int 2008;179:e5-e8.
67. Dolan LP, Toledo MD. Allergic death due to intravenous use of Diodrast. JAMA 1940;114:138-139.
68. Goldburgh H, Baer S. Death following the intravenous administration of Diodrast. JAMA 1942;118:1051-1052.
69. Naterman HL. Cutaneous test with Diodrast to predict allergic systemic reactions. JAMA 1942;119:491-493.
70. Alyea EP, Haines CE. Intradermal test for sensitivity to iodopyracet injection or Diodrast. JAMA 1947;135:25-27.
71. Crepea SB, Allanson JC, Delambre L. The failure of antihistaminic drugs to inhibit Diodrast reactions. N Y State J Med 1949;49:2556-2558.
72. Kanny G, Maria Y, Mentre B, et al. Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction. Allerg Immunol. 1993;25:425-430.
73. Brockow K, Vieluf D, Puschel K, et al. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999;104:237-238.
74. Alvarez-Fernandez JA, Valero AM, Pulido Z, et al. Hypersensitivity reaction to ioversol. Allergy. 2000;55:581-582.
75. Dewachter P, Mouton-Faivre C, Felden F. Allergy and contrast media. Allergy 2001;56:250-251.
76. Valfrey J, Newinger G, Arbogast R, et al. Choc à l'ioxaglate (Hexabrix 320) lors de coronarographies. A propos de 2 cas. Rev Fr Allergol Immunol Clin 2002;42:157-162.
77. Dewachter P, Nicaise-Roland P, Kalaboka S, et al. Anaphylaxis to amidotrizoate proved by skin testing and flow cytometry-based basophil activation test. Allergy 2009;64:501-502.
78. Dewachter P, Mouton-Faivre C. Allergic reaction to contrast medium following gastric band adjustment. Obes Surg 2007;17:1413-1415.
79. Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media: A European multicenter study. Allergy 2009;64:234-241.
80. Lightfoot C, Abraham R, Mammen T, et al. Survey of Radiologists' kwowledge regarding the management of severe contrast material-induced allergic reactions. Radiology 2009;251:691-696.
81. Laroche D, Vergnaud MC, Sillard B, et al. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesthesiology 1991;75:945-949.
82. Morel A, Delaage M. Immunoanalysis of histamine through a novel chemical derivatization. J Allergy Clin Immunol 1988;82:646-654.
83. Simons FER. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 2009;124:625-636.
84. Ebo DG, Fisher MM, Hagendorens MM, et al. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007;62:471-487.
85. Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 2006;117:1411-1414.
86. Laroche D, Aimone-Gastin I, Dubois F, et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998;209:183-190.
87. Mirakian R, Ewan PW, Durham SR, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009;39:43-61.
88. Laroche D, Guilloux L, Gueant JL. Comment rapporter à l'anaphylaxie l'accident observé? Tests diagnostiques in vitro. Ann Fr Anesth Reanim 2002;21(Suppl 1):73s-96s.
89. Gueant JL, Mata E, Monin B, et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991;46:452-458.
90. Guilloux L, Ricard-Blum S, Ville G, et al. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 1992;90:153-159.
91. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: The value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000;28:167-170.
92. Baldo BA, Fisher MM, Pham NH. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 2009;39:325-344.
93. Abuaf N, Rajoely B, Ghazouani E, et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 1999;104(2Pt1):411-418.
94. Monneret G, Benoit Y, Debard AL, et al. Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002;102:192-199.
95. Sudheer PS, Hall JE, Read GF, et al. Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaesthesia 2005;60:251-256.
96. Kvedariene V, Kamey S, Ryckwaert Y, et al. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils. Allergy 2006;61:311-315.
97. Mita H, Tadokoro K, Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998;53:1133-1140.
98. Dewachter P, Mouton-Faivre C, Laroche D, et al. Allergie immédiate aux produits de contraste iodés et prévention des réactions. Rev Med Interne 2009;30:872-881.
99. Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57:45-51.
100. Cottenceau V, Dewachter P, Nouette-Gaulain K, et al. Previous safe administrations of neuromuscular blocking agents do not exonerate from the risk of anaphylactic shock. Ann Fr Anesth Reanim 2008;27:509 e1-e3.
101. Moneret-Vautrin DA. Tests cutanés pour le diagnostic d'allergie aux curares. Ann Fr Anesth Reanim 2002;21(Suppl 1):97s-107s.
102. Guttormsen AB. Allergic reactions during anaesthesia: increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001;45:1189-1190.
103. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001;86:678-682.
104. Bhananker S, O'Donnell J, Salemi J, et al. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg 2005;101:819-822.
105. Torres MJ, Blanca M, Fernandez J, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003;58:961-972.
106. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 2007;136:340-347.
107. Laxenaire MC, Charpentier C, Feldman L. Réactions anaphylactoïdes aux substituts colloïdaux du plasma: incidence, facteurs de risque, mécanismes. Enquête prospective multicentrique française. Ann Fr Anesth Reanim 1994;13:301-310.
108. Mertes PM, Malinovsky JM, Mouton-Faivre C, et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 2008;122:348-352.
109. Dewachter P, Mouton-Faivre C, Trechot P, et al. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 2005;101:149-150.
110. Coakley F V, Panicek DM. Iodine allergy: an oyster without a pearl? AJR Am J Roentgenol 1997;169:951-952.
111. Lopez Saez MP, de Barrio M, Zubeldia JM, et al. Acute IgE-mediated generalized urticaria-angioedema after topical application of povidone-iodine. Allergol Immunopathol 1998;26:23-26.
112. Adachi A, Fukunaga A, Hayashi K, et al. Anaphylaxis to polyvinylpyrrolidone after vaginal application of povidone-iodine. Contact Dermatitis 2003;48:133-136.
113. Le Pabic F, Sainte-Laudy J, Blanchard N. First case of anaphylaxis to iodinated povidone. Allergy 2003;58:826-827.
114. Palobart C, Cros J, Orsel I, et al. Choc anaphylactique à la povidone iodée. Ann Fr Anesth Reanim 2009;28:168-170.
115. Aas K, Jebsen J. Studies of hypersensitivity to fish. Partial purification and crystallization of a major allergenic component of cod. Int Arch Allergy Immunol 1967;32:1-20.
116. Elsayed S, Bennich H. The primary structure of allergen M from cod. Scand J Immunol 1975;4:203-208.
117. Hoffman D. Major heat stable allergen of shrimp. Ann Allergy Asthma Immunol 1981;47:127-132.
118. Dewachter P, Trechot P, Mouton-Faivre C. "Allergie à l'iode": le point sur la question. Ann Fr Anesth Reanim 2005;24:40-52.
119. American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: Part 10.6: anaphylaxis. Circulation 2005;112:IV143-IV145. http://circ.ahajournals.org/cgi/reprint/112/24-suppl/IV- 143.
120. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:1144-1150.
121. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 2004;134:260-261.
122. Schummer W, Schummer C, Wippermann J, et al. Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology 2004;101:1025-1027.
123. Williams SR, Denault AY, Pellerin M, et al. Vasopressin for treatment of shock following aprotinin administration. Can J Anaesth 2004;51:169-172.
124. Hussain AM, Yousuf B, Khan MA, et al. Vasopressin for the management of catecholamine-resistant anaphylactic shock. Singapore Med J 2008;49:e225-e228.
125. Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth 2008;55:437-440.
126. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008;107:620-624.
127. Dewachter P. La prévention du risque allergique peut-elle être assurée par une médication préanesthé sique? Ann Fr Anesth Reanim 2002;21(Suppl 1):151s-167s.
128. Greenberger PA, Patterson R, Tapio CM. Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists. Arch Intern Med 1985;145:2197-2200.
129. Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-849.
130. Marshall GD Jr, Lieberman PL. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media. Ann Allergy 1991;67:70-74.
131. Bertrand PR, Soyer PM, Rouleau PJ, et al. Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media. Radiology 1992;184:383-384.
132. Nilsson S, Bergstrand L, Erikson U, et al. Allergic reactions at repeat femoral angiography with ioxaglate. Acta Radiol 2001;42:608-611.
133. Finby N, Evans JA, Steinberg I. Reactions from intravenous organic iodide compounds: pretesting and prophylaxis. Radiology 1958;71:15-17.
134. Madowitz J, Schweiger M. Severe anaphylactoid reaction to radiographic contrast media. Recurrence despite premedication with diphenylhydramine and prednisone. JAMA 1979;241:2813-2815.
135. Mohan JC, Reddy KS, Bhatia ML. Anaphylactoid reaction to angiographic contrast media: recurrence despite pretreatment with corticosteroids. Cathet Cardiovasc Diagn 1984;10:465-469.
136. Roberts M, Fisher M. Anaphylactoid reaction to iopamiron after pretreatment. Australas Radiol 1992;36:144-146.
137. Ketkar M, Shrier D. An allergic reaction to intraarterial nonionic contrast material. AJNR Am J Neuroradiol 2003;24:292.
138. Armstrong PA, Pazona JF, Schaeffer AJ. Anaphylactoid reaction after retrograde pyelography despite preoperative steroid preparation. Urology 2005;66:880,e1-e2.
139. Worthley DL, Gillis D, Kette F, et al. Radiocontrast anaphylaxis with failure of premedication. Intern Med J 2005;35:58-60.
140. Williams AN, Kelso JM. Radiocontrast-induced anaphylaxis despite pretreatment and use of iso-osmolar contrast. Ann Allergy Asthma Immunol 2007;99:467-468.
141. Chengot T, Goncalves J, Marzo K. Back from irreversibility: use of percutaneous cardiopulmonary bypass for treatment of shock from refractory anaphylaxis during coronary intervention. J Invasive Cardiol 2009;21:e97-e100.
142. Dewachter P, Laroche D, Mouton-Faivre C, et al. Immediate reactions following iodinated contrast media injection: A study of 38 cases. Eur J Radiol 2009;
143. Dewachter P, Laroche D, Mouton-Faivre C, et al. Immediate reactions following iodinated contrast media injection: A study of 38 cases. Eur J Radiol(2009), doi:10.1016/j. ejrad.2009.09.019.
144. Freed KS, Leder RA, Alexander C, et al. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol 2001;176:1389-1392.
145. Tramèr M, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ. 2006;333:675.
146. Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005;60:150-158.
147. Société Française de Radiologie. Comité Interdisciplinaire de Recherche et de Travail sur les Agents de Contraste en Imagerie (CIRTACI). Produits de contraste et allergie: hypersensibilité de type immédiat. Fiche de Recommandations pour la Pratique Clinique. http://www.sfrnet.org/Data/upload/documents/CIRTACI/ Fiche%20Allergie%2029%2009%202009.pdf. Accessed December 14, 2009.